From Vision to Execution: CEO Kevin Kelly Reflects on Cycurion's Strategic Achievements in 2025 in New Interview GlobeNewswire December 09, 2025 MCLEAN, Va., Dec. 09, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a publicly traded leader in technology and staffing solutions for the public sector, today announced the release of […]

Academy Sports + Outdoors Reports Third Quarter Fiscal 2025 Results; Updates Guidance GlobeNewswire December 09, 2025 Third Quarter Sales Increase 3.0%; Comparable Sales Decrease (0.9)% eCommerce Sales Increase 22.2%; New Stores Comping High Single Digits Third Quarter Diluted GAAP EPS of $1.05, +14% to last year Opened Eleven New Stores Across Ten States Narrows Sales

Smackover Lithium Receives Indications of Interest for Over $1 Billion in Project Finance for the SWA Project GlobeNewswire December 09, 2025 All figures are in US dollars unless otherwise stated. LEWISVILLE, Ark., Dec. 09, 2025 (GLOBE NEWSWIRE) — Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI)

Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO GlobeNewswire December 09, 2025 SOMERVILLE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) — Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing(TM), today announced a planned leadership transition in its executive team. After careful

23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer GlobeNewswire December 09, 2025 PALO ALTO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — 23andMe Research Institute, a nonprofit medical research organization, today announced the appointment of John McLeod to the role of General Counsel and Chief Risk Officer. McLeod will be responsible for

Evotrex to Debut World's First Power-Generating RV Trailer at CES 2026 At Booth #10051 in the LVCC North Hall, attendees can get a first look at Evotrex's debut product and explore its mission to enable travelers to roam farther and stay longer GlobeNewswire December 09, 2025 LOS ANGELES, Dec. 09, 2025 (GLOBE NEWSWIRE) — Evotrex,

Eric Herrera Named to Forbes 30 Under 30 for Driving Innovation in Critical Element Extraction Across Energy and Industrial Sectors Co-Founder Jesse Evans and MaverickX Lead the Charge in Sustainable Resource Recovery GlobeNewswire December 09, 2025 SAN ANTONIO, Dec. 09, 2025 (GLOBE NEWSWIRE) — MaverickX, a technology leader in advanced resource recovery, proudly announces that

Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors GlobeNewswire December 09, 2025 PHILADELPHIA, Dec. 09, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. ('Century', NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced the appointments of

Empower Semiconductor Expands Global Footprint with New Silicon Valley Headquarters and Munich R&D Office Scaling a dramatic increase in engineering capacity to meet AI and hyperscaler demand GlobeNewswire December 09, 2025 MILPITAS, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Empower Semiconductor, the world leader in powering artificial intelligence (AI)-class processors, today announced a major expansion

Gaxos Enters Multibillion-Dollar Digital Faith Market with Launch of Bible Pray AI GlobeNewswire December 09, 2025 Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform